Sign in
CWBR Stock Price, Chart, Stats & News
CohBar, Inc.
Save
CohBar, Inc. (CWBR) does not currently pay a dividend.
1.19M
Market cap
–
Current P/E
–
Forward P/E
CWBR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 1.75% |
ROA | -73.09% |
ROE | -58.44% |
D/E | – |
Interest coverage ratio | -1214.30x |
CWBR valuation
P/E | – |
P/S | – |
P/B | 0.08x |
P/CF | -0.11x |
P/FCF | -0.11x |
P/OCF | -0.11x |
PEG | -0.00x |
EV multiple | -0.59x |
About
CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease.
Similar securities
Based on sector and market capitalization
Report issue